Differential pricing: How stent makers want patients, doctors to benefit

The National Pharmaceutical Pricing Authority (NPPA) on Monday said they have decided to meet again on February 8 to deliberate on the new stent prices.

"After day-long hearing of the views of all the stakeholders, Authority to meet again on February 08, as an extended meeting, to deliberate on new stent prices with the concerns of all on board," said the NPPA in a tweet.

According to industry leaders, the price cap has left little room for innovation, leaving patients with few options.

Earlier, the NPPA had decided to meet on February 5 with the stakeholders to decide on the